Award
Delivery Order #SPE2DP26F3459
Delivery Order for Loratadine Tablets to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$11.95
Ceiling
$11.95
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 26, 2026
Identifier
SPE2DP26F3459
NAICS
424210
This delivery order contract represents a recently awarded supplemental agreement under the definitive pharmaceutical supply contract to DMS Pharmaceutical Group Inc., a specialized distributor of pharmaceutical products. The order specifically procures loratadine tablets, an essential medication used for allergy relief, contributing to ongoing federal health agency pharmaceutical needs. The significance of this contract lies in its reinforcement of the sustained supply chain reliability for critical medications, complementing the broader pharmaceutical coverage under the parent indefinite delivery vehicle. The scope of work includes delivery and supply of the specified loratadine tablets within a focused short-term timeframe, ensuring timely medical support. This delivery order falls under the umbrella of a strategic, competitively managed procurement program evidenced by the parent contract, although specific solicitation details for this order are not available. Performance is scheduled over a concise period in early 2026 at the designated location in Park Ridge, Illinois, reflecting a well-defined, immediate need fulfillment within the agency's pharmaceutical acquisition strategy.
Description
8511970616!LORATADINE TABLETS